Nanotechnology Drug Delivery Market Size, Share, and Trends 2024 to 2034

The global nanotechnology drug delivery market size is accounted at USD 105.95 billion in 2025 and is forecasted to hit around USD 209.73 billion by 2034, representing a CAGR of 7.91% from 2025 to 2034. The North America market size was estimated at USD 39.19 billion in 2024 and is expanding at a CAGR of 7.94% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : January 2025
  • Report Code : 2762
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID-19 Impact on Nanotechnology Drug Delivery Market 

5.1. COVID-19 Landscape: Nanotechnology Drug Delivery Industry Impact

5.2. COVID-19 - Impact Assessment for the Industry

5.3. COVID-19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Nanotechnology Drug Delivery Market, By Technology

8.1. Nanotechnology Drug Delivery Market, by Technology

8.1.1. Nanocrystals

8.1.1.1. Market Revenue and Forecast

8.1.2. Nanoparticles

8.1.2.1. Market Revenue and Forecast

8.1.3. Liposomes

8.1.3.1. Market Revenue and Forecast

8.1.4. Micelles

8.1.4.1. Market Revenue and Forecast

8.1.5. Nanotubes

8.1.5.1. Market Revenue and Forecast

8.1.6. Others

8.1.6.1. Market Revenue and Forecast

Chapter 9. Global Nanotechnology Drug Delivery Market, By Application

9.1. Nanotechnology Drug Delivery Market, by Application

9.1.1. Neurology

9.1.1.1. Market Revenue and Forecast

9.1.2. Oncology

9.1.2.1. Market Revenue and Forecast

9.1.3. Cardiovascular/Physiology

9.1.3.1. Market Revenue and Forecast

9.1.4. Anti-Inflammatory / Immunology

9.1.4.1. Market Revenue and Forecast

9.1.5. Anti-infective

9.1.5.1. Market Revenue and Forecast

9.1.6. Others

9.1.6.1. Market Revenue and Forecast

Chapter 10. Global Nanotechnology Drug Delivery Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Technology

10.1.2. Market Revenue and Forecast, by Application

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Technology

10.1.3.2. Market Revenue and Forecast, by Application

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Technology

10.1.4.2. Market Revenue and Forecast, by Application

10.2. Europe

10.2.1. Market Revenue and Forecast, by Technology

10.2.2. Market Revenue and Forecast, by Application

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Technology

10.2.3.2. Market Revenue and Forecast, by Application

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Technology

10.2.4.2. Market Revenue and Forecast, by Application

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Technology

10.2.5.2. Market Revenue and Forecast, by Application

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Technology

10.2.6.2. Market Revenue and Forecast, by Application

10.3. APAC

10.3.1. Market Revenue and Forecast, by Technology

10.3.2. Market Revenue and Forecast, by Application

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Technology

10.3.3.2. Market Revenue and Forecast, by Application

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Technology

10.3.4.2. Market Revenue and Forecast, by Application

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Technology

10.3.5.2. Market Revenue and Forecast, by Application

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Technology

10.3.6.2. Market Revenue and Forecast, by Application

10.4. MEA

10.4.1. Market Revenue and Forecast, by Technology

10.4.2. Market Revenue and Forecast, by Application

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Technology

10.4.3.2. Market Revenue and Forecast, by Application

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Technology

10.4.4.2. Market Revenue and Forecast, by Application

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Technology

10.4.5.2. Market Revenue and Forecast, by Application

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Technology

10.4.6.2. Market Revenue and Forecast, by Application

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Technology

10.5.2. Market Revenue and Forecast, by Application

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Technology

10.5.3.2. Market Revenue and Forecast, by Application

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Technology

10.5.4.2. Market Revenue and Forecast, by Application

Chapter 11. Company Profiles

11.1. Novartis International AG

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Taiwan Liposome Company

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Johnson and Johnson

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Merck and Co., Inc

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Tarveda Therapeutics

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Celgene Corporation

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. AbbVie, Inc.

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Amgen, Inc

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Nanobiotix

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. NanoCarrier Corporation

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global nanotechnology drug delivery market size is expected to increase USD 209.73 billion by 2034 from USD 97.98 billion in 2024.

The global nanotechnology drug delivery market will registered growth rate of 7.91% between 2025 and 2034.

The major players operating in the nanotechnology drug delivery market are Novartis International AG, Taiwan Liposome Company, Johnson and Johnson, Merck and Co., Inc, Tarveda Therapeutics, Celgene Corporation, AbbVie, Inc., Amgen, Inc, Nanobiotix, NanoCarrier Corporation and Others.

The driving factors of the nanotechnology drug delivery market are the main advantages of nanoparticles are improved bioavailability by improving liquefied dissolvability, increasing incidence of chronic diseases, and growing pharmaceutical drug development.

North America region will lead the global nanotechnology drug delivery market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client